Pharmaceutical

US Food and Drug Administration's Phase II consolidation includes a new headquarters at the 700-acre site of the former Naval Surface Warfare Center in Montgomery County, Md. Pending approval of an advance $101,239,000 appropriation in the fiscal 2001 budget, construction would begin in fall 2000 on the new 111,250-sf Center for Drug Evaluation and Research Laboratories. The design for a new lab and office for the Center for Devices and Radiological Health would be included in the appropriation as well.

Wyeth-Lederle Vaccines and Pediatrics plans to produce two new vaccines at its plant in Sanford. Part of the existing 160,000-sf facility will be renovated and a 46,400-sf addition will be built. Wyeth-Lederle has awarded a contract for renovation of three of the labs to InServ's Construction Services Group. The total project cost is $48 million, most of which will purchase new equipment needed for the vaccine products. Wyeth-Lederle is a division of American Home Products Corp.

Aventis SA, based in Strasbourg, France, is expanding its Genomics Center in Cambridge. Completion of the $3 million renovation, which will improve lab and office space at the pharmaceutical company, is anticipated in mid-July. Kennedy & Rossi Inc. of Lexington, Mass., is in charge of the project.

Quintiles Transnational is building a new $3.4 million, 103,000-sf facility, Bradford Place, to consolidate its ten Research Triangle Park offices in one location. Construction began in July 1999 and is scheduled for completion in June 2000. Architects for the project are WGM Design Inc., based in Charlotte, N.C., and Bell/Knott Associates, based in Kansas City, Kan. The general contractor is the Raleigh, N.C., office of Shelco Inc., headquartered in Charlotte.

Tompkins Associates and MARC Systems have entered into a strategic alliance to offer seamless supply chain solutions to the pharmaceutical and health care industries. Through the joint efforts of the respective sales and marketing teams, Tompkins and MARC Systems will enable clients to integrate supply chain execution software with operations best practices. With its extensive functionality and strict inventory control, the MARC product suite is utilized by major pharmaceutical companies to distribute some of the most carefully controlled substances in use.

Serono Laboratories Inc., based in Norwell, Mass., plans to consolidate its offices and labs at a new $20 million, 200,000-sf headquarters that will straddle the town line between Hingham and Rockland. A.W. Perry Inc. of Boston is the developer on the project. Construction has not yet begun, but move-in is scheduled for late 2000.

Serono Labs is a drug-development company and a subsidiary of Ares-Serono Group SA of Geneva, Switz.

EMD Pharmaceuticals, a subsidiary of Germany-based Merck KgaA, is building a 148,000-sf marketing, sales, and clinical research facility in Durham. The Indra Group is the developer of the project.